Similar Search Results

Projecting Vaccine Efficacy: Accounting for Geographic Strain Variations

Rose, Johnie; Singer, Mendel E. - In: PharmacoEconomics 26 (2008) 3, pp. 185-189

Researchers must often make assumptions about the efficacy of an intervention in a target population without the benefit of trial data specific to that population. Such assumptions may be particularly tenuous with models of vaccination strategies, since the distribution of pathogen strains in...

Persistent link: https://www.econbiz.de/10005449268

Cost-Effectiveness Analyses of Hepatitis A Vaccine: A Systematic Review to Explore the Effect of Methodological Quality on the Economic Attractiveness of Vaccination Strategies

Anonychuk, Andrea M.; Tricco, Andrea C.; Bauch, Chris T.; … - In: PharmacoEconomics 26 (2008) 1, pp. 17-32

populations, and explores the effects of methodological quality and key modelling issues on the cost-effectiveness ratios. Cost …, methodological issues and key modelling issues were assessed using frameworks published in the literature. Thirty-one cost …

Persistent link: https://www.econbiz.de/10005449289

Management of Schizophrenia: Defining the Role of Long-Acting Injectable Risperidone

Curran, Monique P.; Keating, Gillian M. - In: Disease Management and Health Outcomes 14 (2006) 2, pp. 107-125

Schizophrenia is a chronic disease that typically manifests during adolescence and early adulthood. Treatment of this disease consumes a significant proportion of the healthcare budget (billions of dollars in the US). Primary management options for schizophrenia include both pharmacologic and...

Persistent link: https://www.econbiz.de/10005404603

Incorporation of Uncertainty in Health Economic Modelling Studies

Nuijten, Mark - In: PharmacoEconomics 23 (2005) 8, pp. 851-853

Persistent link: https://www.econbiz.de/10005404801

Economic Models of Antiretroviral Therapy: Searching for the Optimal Strategy

Hellinger, Fred J. - In: PharmacoEconomics 24 (2006) 7, pp. 631-642

The diffusion of protease inhibitors and non-nucleoside reverse transcriptase inhibitors in the US in 1996 and 1997 reduced the number of deaths attributable to HIV disease and changed the way we think about the illness. Today, HIV disease may be deemed a fairly expensive chronic condition...

Persistent link: https://www.econbiz.de/10005404811

Modelling Methods for Pharmacoeconomics and Health Technology Assessment: An Overview and Guide

Stahl, James E. - In: PharmacoEconomics 26 (2008) 2, pp. 131-148

modelling methods as applied to healthcare. What simulation is and why it is necessary in addressing healthcare problems are …

Persistent link: https://www.econbiz.de/10005404870

Modelling Approaches: The Case of Schizophrenia

Heeg, Bart M.S.; Damen, Joep; Buskens, Erik; Caleo, Sue; … - In: PharmacoEconomics 26 (2008) 8, pp. 633-648

even intra-individual variability. We provide a critical assessment of the advantages and disadvantages of three modelling … simulation models. These modelling techniques are compared in terms of building time, data requirements, medico …, depending on the research question, the optimal modelling approach should be selected based on the expected differences between …

Persistent link: https://www.econbiz.de/10005404892

Assessing Generalisability in Model-Based Economic Evaluation Studies: A Structured Review in Osteoporosis

Urdahl, Hege; Manca, Andrea; Sculpher, Mark J. - In: PharmacoEconomics 24 (2006) 12, pp. 1181-1197

variability in cost effectiveness across locations is addressed to a varying extent in modelling studies in the field of …

Persistent link: https://www.econbiz.de/10005404948

Inclusion of Compliance and Persistence in Economic Models: Past, Present and Future

Kadambi, Ananth; Leipold, Robert J.; Kansal, Anuraag R.; … - In: Applied Health Economics and Health Policy 10 (2012) 6, pp. 365-379

economic models. In this review, we present a discussion of the current state of economic modelling as it relates to the … in economic models and provide an in-depth review of recent modelling literature that considers compliance or persistence … increasing number of economic models that consider these factors, as well as the use of more sophisticated modelling techniques …

Persistent link: https://www.econbiz.de/10010586221

A Review of Methods Used in Long-Term Cost-Effectiveness Models of Diabetes Mellitus Treatment

Tarride, Jean-Eric; Hopkins, Robert; Blackhouse, Gord; … - In: PharmacoEconomics 28 (2010) 4, pp. 255-277

Diabetes mellitus is a major healthcare concern from both a treatment and a funding perspective. Although decision makers frequently rely on models to evaluate the long-term costs and consequences associated with diabetes interventions, no recent article has reviewed the methods used in...

Persistent link: https://www.econbiz.de/10008602823